Sign Up Today and Learn More About LumaCyte Stock
Invest in or calculate the value of your shares in LumaCyte or other pre-IPO companies through EquityZen's platform.
LumaCyte Stock (LUMC)
LumaCyte provides researchers with a diagnostic tool that accelerates medical discoveries through a novel approach to cell analysis.
About LumaCyte Stock
Founded
2012
Headquarters
Keswick, VA, US
Industries
Software, Artificial Intelligence, Data and Analytics
LumaCyte Press Mentions
Stay in the know about the latest news on LumaCyte
Humacyte’s (HUMA) Statements to Investors Called Into Question in Light of FDA Violations – Hagens Berman
morningstar • Nov 28, 2024
LumaCyte Unveils Predictive CAR T Donor Analytics to Revolutionize Cell Therapy Manufacturing
businesswire • Sep 05, 2024
LumaCyte Launches Laser Force Cytology™ Academy after Training FDA Reviewers
businesswire • Aug 01, 2024
Microfluidic devices and method for sampling and analysis of cells using …
patents • Apr 13, 2024
Microfluidic chip device for optical force measurements and cell imaging using …
patents • Apr 13, 2024
LumaCyte Management
Leadership team at LumaCyte
Managing Director, Advisor
Renee A. Hart
Chief Executive Officer & Chief Scientific Officer
Sean J. Hart
Join now and verify your accreditation status to gain access to:
- LumaCyte current valuation
- LumaCyte stock price
- Available deals in LumaCyte and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading LumaCyte Stock
How to invest in LumaCyte stock?
Accredited investors can buy pre-IPO stock in companies like LumaCyte through EquityZen funds. These investments are made available by existing LumaCyte shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell LumaCyte stock?
Shareholders can sell their LumaCyte stock through EquityZen's private company marketplace. EquityZen's network includes over 340K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
